T

TxCell

14 employees

TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immunology
Cell therapy
Ophtalmology
Therapeutics
Gastroenterology
Pharmaceutical

Date founded

2001

Funding rounds raised

Total raised

$21M

from 6 investors over 6 rounds

T

TxCell raised $12M on February 24, 2017

Investors: Auriga Partners

T

TxCell raised $21M on April 14, 2014

Investors: Auriga Partners

T

TxCell raised $16M on November 26, 2012

Investors: Seventure Partners and Auriga Partners

T

TxCell raised $16M on February 1, 2008

Investors: Auriga Partners and Ardian

FAQ